Samrat Pharmachem Ltd
BSE:530125

Watchlist Manager
Samrat Pharmachem Ltd Logo
Samrat Pharmachem Ltd
BSE:530125
Watchlist
Price: 202.5 INR -3.32% Market Closed
Market Cap: ₹625.7m

Relative Value

The Relative Value of one SAMRATPH stock under the Base Case scenario is hidden INR. Compared to the current market price of 202.5 INR, Samrat Pharmachem Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SAMRATPH Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

SAMRATPH Competitors Multiples
Samrat Pharmachem Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Samrat Pharmachem Ltd
BSE:530125
625.7m INR 0.2 40.2 13.5 16.2
US
Sherwin-Williams Co
NYSE:SHW
86.7B USD 3.7 33.6 22.5 26.4
US
Ecolab Inc
NYSE:ECL
79.9B USD 5 40.2 22.9 30.7
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
9.1T JPY 3.5 18.4 8.7 11.9
CN
Wanhua Chemical Group Co Ltd
SSE:600309
274.1B CNY 1.5 24.7 21.2 21.2
CH
Givaudan SA
SIX:GIVN
28.7B CHF 3.9 26.5 18 22.7
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.4T INR 7 61.9 38 46.8
US
PPG Industries Inc
NYSE:PPG
26B USD 1.8 25.8 11.6 14.3
CH
Sika AG
F:SIKA
19.9B EUR 1.3 12 8.1 10.2
US
Albemarle Corp
NYSE:ALB
21.6B USD 4.4 -115.6 33.8 1 130.4
P/E Multiple
Earnings Growth PEG
IN
Samrat Pharmachem Ltd
BSE:530125
Average P/E: 33.8
40.2
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
33.6
9%
3.7
US
Ecolab Inc
NYSE:ECL
40.2
9%
4.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
18.4
7%
2.6
CN
Wanhua Chemical Group Co Ltd
SSE:600309
24.7
13%
1.9
CH
Givaudan SA
SIX:GIVN
26.5
6%
4.4
DK
Novozymes A/S
CSE:NZYM B
54.8
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
61.9
16%
3.9
US
PPG Industries Inc
NYSE:PPG
25.8
21%
1.2
CH
Sika AG
F:SIKA
12
5%
2.4
US
Albemarle Corp
NYSE:ALB
Negative Multiple: -115.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Samrat Pharmachem Ltd
BSE:530125
Average EV/EBITDA: 20.6
13.5
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
22.5
7%
3.2
US
Ecolab Inc
NYSE:ECL
22.9
9%
2.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
8.7
4%
2.2
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.2
33%
0.6
CH
Givaudan SA
SIX:GIVN
18
5%
3.6
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
38
11%
3.5
US
PPG Industries Inc
NYSE:PPG
11.6
4%
2.9
CH
Sika AG
F:SIKA
8.1
4%
2
US
Albemarle Corp
NYSE:ALB
33.8
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Samrat Pharmachem Ltd
BSE:530125
Average EV/EBIT: 124.4
16.2
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
26.4
8%
3.3
US
Ecolab Inc
NYSE:ECL
30.7
12%
2.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.9
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.2
8%
2.6
CH
Givaudan SA
SIX:GIVN
22.7
5%
4.5
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
46.8
11%
4.3
US
PPG Industries Inc
NYSE:PPG
14.3
5%
2.9
CH
Sika AG
F:SIKA
10.2
5%
2
US
Albemarle Corp
NYSE:ALB
1 130.4
N/A N/A